[The effect of Visnadine in chronic degenerative myocardial lesions].
D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001578:Benzopyrans / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D002867:Chromones / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D006801:Humans; D007666:Khellin / Q000627:therapeutic use; D007783:Lactones / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D001578:Benzopyrans; D002087:Butyrates; D002867:Chromones; D007783:Lactones; D014665:Vasodilator Agents; D000628:Aminophylline; D007666:Khellin
Die Wirkung von Visnadin bei chronisch-degenerativen Myocardschäden.